응급 피임약 시장 규모, 점유율 및 성장 분석 : 약제 유형별, 가용성별, 유통경로별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Emergency Contraceptive Pills Market size was valued at USD 1.52 Billion in 2024 and is poised to grow from USD 1.61 Billion in 2025 to USD 2.52 Billion by 2033, growing at a CAGR of 5.81% during the forecast period (2026-2033).

The global emergency contraceptive pills market is experiencing significant growth, primarily driven by the integration of digital health solutions. The rise of telemedicine prescriptions and app-based counseling has notably improved sales efficiency, evidenced by a substantial increase in medication ordering frequency upon the introduction of delivery platforms. This convenience has prompted manufacturers to invest in diverse formulations, catering to various consumer needs and expanding market niches. Additionally, the relaxation of import restrictions in regions like Latin America and Sub-Saharan Africa presents valuable opportunities for multinational companies to meet unmet demand while reinforcing their supply chains through strategic partnerships and localized distribution. The adoption of AI is also transforming the sector, streamlining formulation research, optimizing clinical testing, and enhancing operational efficiencies to better address public health challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Emergency Contraceptive Pills market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Emergency Contraceptive Pills Market Segments Analysis

The global emergency contraceptive pills market is segmented based on drug type, availability, distribution channel, end-user, and region. By drug type, the market is categorized into Levonorgestrel-Based Pills (such as Plan B), Ulipristal Acetate (such as ella), and Combined Estrogen-Progestin Pills (Yuzpe Method). Based on availability, the market is divided into Over-the-Counter (OTC) and Prescription products. By distribution channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Family Planning Clinics. Based on end-user, the market primarily serves Women of Reproductive Age. Geographically, the market is analyzed across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Driver of the Global Emergency Contraceptive Pills Market

The growth of the Global Emergency Contraceptive Pills market is significantly influenced by the rising awareness among women. This heightened understanding is largely facilitated by educational initiatives, social media campaigns, and programs within educational institutions, which provide essential information about the safety, usage, and availability of emergency contraceptive options. As women become more informed about the real benefits of these pills, they tend to view them as a responsible choice for managing unplanned pregnancies, thus broadening the demand across various demographic segments. Additionally, this awareness encourages healthcare providers to incorporate these products into routine consultations, further enhancing their visibility and accessibility. This cycle of increasing confidence fosters repeat purchases and generates positive word-of-mouth referrals, contributing to sustained market growth as new customers continuously enter the market.

Restraints in the Global Emergency Contraceptive Pills Market

The global market for emergency contraceptive pills faces significant limitations due to regulatory constraints on over-the-counter sales. These regulations often mandate prescriptions or restrict sales to designated healthcare environments, necessitating additional steps for consumers to access these products. This can hinder immediate purchasing decisions, as consumers may find the process cumbersome. Retailers may be reluctant to stock emergency contraceptives due to concerns regarding compliance, leading to tighter distribution channels and reduced visibility for potential users. Consequently, these factors can impede widespread adoption and may inadvertently drive demand toward informal markets, where the lack of quality control poses challenges for public health initiatives and complicates oversight for healthcare professionals.

Market Trends of the Global Emergency Contraceptive Pills Market

The Global Emergency Contraceptive Pills market is experiencing a significant shift driven by the integration of digital health solutions. Telemedicine platforms and mobile health applications are transforming access to emergency contraceptives by offering discreet consultations, electronic prescriptions, and convenient doorstep delivery. This seamless integration reduces traditional barriers to clinic visits, particularly appealing to younger, tech-savvy individuals. Enhanced user engagement through reminder notifications and educational content promotes responsible family planning choices across diverse demographics. As digital channels become the primary distribution pathways, they are reshaping consumer behavior and fueling growth in the emergency contraceptive sector worldwide, reflecting a broader trend towards accessible reproductive health services.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Emergency Contraceptive Pills Market Size by Drug Type & CAGR (2026-2033)

• Market Overview
• Levonorgestrel-Based (Plan B)
• Ulipristal Acetate (ella)
• Combined Estrogen-Progestin (Yuzpe)

Global Emergency Contraceptive Pills Market Size by Availability & CAGR (2026-2033)

• Market Overview
• OTC (Over-the-Counter)
• Prescription

Global Emergency Contraceptive Pills Market Size by Distribution & CAGR (2026-2033)

• Market Overview
• Retail Pharmacies
• Hospital Pharmacies
• Online
• Family Planning Clinics

Global Emergency Contraceptive Pills Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Women of Reproductive Age

Global Emergency Contraceptive Pills Market Size & CAGR (2026-2033)

• North America (Drug Type, Availability, Distribution, End-User)
  • US
  • Canada
• Europe (Drug Type, Availability, Distribution, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Drug Type, Availability, Distribution, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Drug Type, Availability, Distribution, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Drug Type, Availability, Distribution, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Gedeon Richter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (Plan B One-Step)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HRA Pharma (ella, ellaOne)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Mirena, Jaydess)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan (Viatris)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Actavis (Allergan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novavax Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Afaxys Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Cadila
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apotex Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amneal Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glenmark Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emcure Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations